Early and Late Outcomes of Endovascular Aneurysm Repair for Infected Abdominal Aortic and/or Iliac Aneurysms


      Infected abdominal aortic and/or iliac aneurysm (AAIA) is a rare condition with a high mortality rate when treated with open surgery. In the past decade, the condition has increasingly been treated with endovascular aneurysm repair (EVAR). However, early and late outcomes, including the continued need for antibiotic treatments and predictors of persistent infection, are poorly understood.


      We evaluated the outcomes of patients who underwent EVAR for infected AAIA from January 2010 to October 2017. We collected data including patient age, gender, clinical presentation, aneurysm location, culture results, intraoperative details, postoperative complications, 30-day mortality, in-hospital mortality, persistent infection, reintervention, and survival.


      Among 792 patients diagnosed with AAIA, 64 were diagnosed with primary infected aneurysm, underwent EVAR, and were included in this study (81.3% male; median age, 72 years; range, 18–94 years). The most commonly isolated organisms were Salmonella species (34%), followed by Streptococcus (21%), and Staphylococcus species (21%). Aneurysms were intact in 48 patients (75%) and were ruptured in 16 (25%). The perioperative mortality was 4.7% (3 patients) of whom one was diagnosed with ruptured infected AAIA. Six (9.4%) patients died during hospitalization, 5 of severe sepsis with multiorgan failure and one of myocardial infarction. Among the 58 surviving patients, 34 (58.6%) had persistent infection, of whom 13 (22.4%) required early and late reintervention, including 2 with endograft infection, 8 with primary and secondary aortoenteric fistula, 2 with recurrent new aortic infection, and one with graft limb occlusion. The remaining 24 patients were able to discontinue antibiotics and had no recurrence or need for reintervention. Overall survival rates at 1, 3, and 5 years in the antibiotic-discontinuation group were 91.7%, 87.5%, and 68.0%, respectively, and 82.4%, 52.6%, and 32.9%, respectively, in the persistent-infection group (P = 0.009). In multivariable analysis, primary aortoenteric fistula (Adjusted OR [aOR], 20.469; 95% confidence interval (CI), 1.265–331.320; P = 0.034) and preoperative serum albumin level <3 g/dL (aOR, 7.399; 95% CI, 1.176–46.558; P = 0.033) were preoperative parameter that predicted persistent infection. A C-reactive protein level more than 5 mg/L (aOR, 34.378; 95% CI, 4.888–241.788; P < 0.001) was observed in patients with persistent infection.


      EVAR is a feasible treatment with acceptable perioperative mortality for infected AAIA. Patients able to discontinue antibiotics have better survival and lower reintervention rates than those with persistent infection. A preoperative albumin level below 3 g/dL and primary aortoenteric fistula predicted persistent infection in this population.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Reddy D.J.
        • Shepard A.D.
        • Evans J.R.
        • et al.
        Management of infected aortoiliac aneurysms.
        Arch Surg. 1991; 126: 873-878
        • Clough R.E.
        • Black S.A.
        • Lyons O.T.
        • et al.
        Is endovascular repair of mycotic aortic aneurysms a durable treatment option?.
        Eur J Vasc Endovasc Surg. 2009; 37: 407-412
        • Luo C.Y.
        • Ko W.C.
        • Kan C.D.
        • et al.
        In situ reconstruction of septic aortic pseudoaneurysm due to Salmonella or Streptococcus microbial aortitis: long-term follow-up.
        J Vasc Surg. 2003; 38: 975-982
        • Gross C.
        • Harringer W.
        • Mair R.
        • et al.
        Mycotic aneurysms of the thoracic aorta.
        Eur J Cardiothorac Surg. 1994; 8: 135-138
        • Ihaya A.
        • Chiba Y.
        • Kimura T.
        • et al.
        Surgical outcome of infectious aneurysm of the abdominal aorta with or without SIRS.
        Cardiovasc Surg. 2001; 9: 436-440
        • Müller B.T.
        • Wegener O.R.
        • Grabitz K.
        • et al.
        Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases.
        J Vasc Surg. 2001; 33: 106-113
        • Leon Jr., L.R.
        • Mills Sr., J.L.
        Diagnosis and management of aortic mycotic aneurysms.
        Vasc Endovascular Surg. 2010; 44: 5-13
        • Sorelius K.
        • Wanhainen A.
        • Furebring M.
        • et al.
        Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair.
        Circulation. 2016; 134: 1822-1832
        • Sorelius K.
        • Budtz-Lilly J.
        • Mani K.
        • et al.
        Systematic review of the management of mycotic aortic aneurysms.
        Eur J Vasc Endovasc Surg. 2019; 58: 426-435
        • Stenson K.M.
        • Grima M.J.
        • Loftus I.M.
        • et al.
        Recommendations for management of infected aortic pathology based on current evidence.
        Semin Vasc Surg. 2019; 32: 68-72
        • Vallejo N.
        • Picardo N.E.
        • Bourke P.
        • et al.
        The changing management of primary mycotic aortic aneurysms.
        J Vasc Surg. 2011; 54: 334-340
        • Luo C.M.
        • Chan C.Y.
        • Chen Y.S.
        • et al.
        Long-term outcome of endovascular treatment for mycotic aortic aneurysm.
        Eur J Vasc Endovasc Surg. 2017; 54: 464-471
        • Chaikof E.L.
        • Blankensteijn J.D.
        • Harris P.L.
        • et al.
        Reporting standards for endovascular aortic aneurysm repair.
        J Vasc Surg. 2002; 35: 1048-1060
        • Chakfé N.
        • Diener H.
        • Lejay A.
        • et al.
        Editor's choice - European society for vascular surgery (ESVS) 2020 clinical practice guidelines on the management of vascular graft and endograft infections.
        Eur J Vasc Endovasc Surg. 2020; 59: 339-384
        • Chaikof E.L.
        • Dalman R.L.
        • Eskandari M.K.
        • et al.
        The society for vascular surgery practice guidelines on the care of patients with an abdominal aortic aneurysm.
        J Vasc Surg. 2018; 67: 2-77.e2
        • Vu Q.D.
        • Menias C.O.
        • Bhalla S.
        • et al.
        Aortoenteric fistulas: CT features and potential mimics.
        Radiographics. 2009; 29: 197-209
        • Demidenko E.
        Sample size determination for logistic regression revisited.
        Stat Med. 2007; 26: 3385-3397
        • Forbes T.L.
        • Harding G.E.
        Endovascular repair of Salmonella-infected abdominal aortic aneurysms: a word of caution.
        J Vasc Surg. 2006; 44: 198-200
        • Lew W.K.
        • Rowe V.L.
        • Cunningham M.J.
        • et al.
        Endovascular management of mycotic aortic aneurysms and associated aortoaerodigestive fistulas.
        Ann Vasc Surg. 2009; 23: 81-89
        • Kritpracha B.
        • Premprabha D.
        • Sungsiri J.
        • et al.
        Endovascular therapy for infected aortic aneurysms.
        J Vasc Surg. 2011; 54: 1259-1265
        • Ginn A.N.
        • Halliday C.L.
        • Douglas A.P.
        • et al.
        PCR-based tests for the early diagnosis of sepsis. Where do we stand?.
        Curr Opin Infect Dis. 2017; 30: 565-572
        • Sedivy P.
        • Spacek M.
        • El Samman K.
        • et al.
        Endovascular treatment of infected aortic aneurysms.
        Eur J Vasc Endovasc Surg. 2012; 44: 385-394
        • Champion M.C.
        • Sullivan S.N.
        • Coles J.C.
        • et al.
        Aortoenteric fistula. Incidence, presentation recognition, and management.
        Ann Surg. 1982; 195: 314-317
        • Kakkos S.K.
        • Papadoulas S.
        • Tsolakis I.A.
        Endovascular management of arterioenteric fistulas: a systemic review and meta-analysis of the literature.
        J Endovasc Ther. 2011; 18: 66-77
        • Laohapensang K.
        • Arworn S.
        • Orrapin S.
        • et al.
        Management of the infected aortic endograft.
        Semin Vasc Surg. 2017; 30: 91-94
        • Moulakakis K.G.
        • Sfyroeras G.S.
        • Mylonas S.N.
        • et al.
        Outcome after preservation of infected abdominal aortic endografts.
        J Endovasc Ther. 2014; 21: 448-455
        • Sorelius K.
        • Sundbom M.
        • Mani K.
        • et al.
        Hybrid treatment of a post-EVAR aortoenteric fistula.
        Vascular. 2014; 22: 385-389
        • Treglia G.
        Diagnostic performance of (18)F-FDG PET/CT in infectious and inflammatory diseases according to published meta-analyses.
        Contrast Media Mol Imaging. 2019; 2019: 3018349
        • Soeters P.B.
        • Wolfe R.R.
        • Shenkin A.
        Hypoalbuminemia: pathogenesis and clinical significance.
        J Parenter Enteral Nutr. 2019; 43: 181-193
        • Wiedermann C.J.
        Hypoalbuminemia as surrogate and culprit of infections.
        Int J Mol Sci. 2021; 22: 4496
        • Lonn L.
        • Dias N.
        • Veith Schroeder T.
        • et al.
        Is EVAR the treatment of choice for aortoenteric fistula?.
        J Cardiovasc Surg. 2010; 51: 319-327
        • Guo Y.
        • Bai Y.
        • Yang C.
        • et al.
        Mycotic aneurysm due to Salmonella species: clinical experiences and review of the literature.
        Braz J Med Biol Res. 2018; 51: e6864